نتایج جستجو برای: pharmaceutical parent company structure

تعداد نتایج: 1758482  

Journal: :Statistics in Biopharmaceutical Research 2022

Zhen Zhanga, Yong Linb* & Jingyi Liuba Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJb Eli Lilly Company, Indianapolis, IN

Alimohammad Zanganeh, Masoud Zareian, Mohsen Jallalat-Danesh, Nader Mansurkiaie, Saeed Akbari-Zardkhaneh, Seyed Mohammad Shahvarani, Siamak Tahmasebi Garmtani,

Objectives To the importance of screening students’ mental health and lack of a customized tool based on prevalent psychopathological problems in students, the present study aims to develop and examine the psychometric properties of electronic mental health assessment device for high school students-parent form and teacher form.  Methods The study sample included 1697 teachers and 1186 parents...

2016
H. Sharma J. Sietsma S. E. Offerman

Polymorphism is the ability of a solid material to exist in more than one phase or crystal structure. Polymorphism may occur in metals, alloys, ceramics, minerals, polymers, and pharmaceutical substances. Unresolved are the conditions for preferential nucleation during polymorphic transformations in which structural relationships or special crystallographic orientation relationships (OR's) form...

2017
Kati Heiskanen Riitta Ahonen Risto Kanerva Pekka Karttunen Johanna Timonen

The aim of this study was to explore the reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland. The study took the form of semi-structured interviews. Forty-one pharmaceutical companies and pharmaceutical wholesalers were invited to participate in the study. The pharmaceutical companies were the member organizations of Pharm...

Journal: پژوهنده 2018
Ahmadreza Kiani, Sajjad Rashid, Sanaz Einy, Yasaman jamshidian, Zahra Rashidi Vala,

The present study was aimed to examine the relationship between parental report about their children’s obsessive-compulsive disorder symptoms and thought fusion with the parent-child relationship structure among the adolescents with obsessive-compulsive disorder. The research method was correlational descriptive and the statistical population included all the adolescents affected by obsessive c...

2013
Erika Kutscher Richard de Neufville

Airlines have been recently debated the management of some of their non-core divisions, such as the Frequent Flyer Program (FFP).A spinoff is a form of corporate contraction that many companies have recently chosen. Through a spinoff, both the parent company and the divested subsidiary can each focus on their own activity, which translates into a better performance of both entities. This thesis...

2002
Kris Steenhaut Tim Hoebeek Tom Tourwé

The media and TV world faces new challenges such as the introduction of digital and interactive TV. In order to cope with the complexity of these new services, a well-structured back office is of prime importance. Today, efficient management of content is hampered by the proprietary formats used in the different software applications that have been developed by various vendors. Moreover, the la...

Journal: :Akuntansi : jurnal akuntansi integratif 2022

Abstract This study aims to determine the effect of company characteristics and corporate governance on internet financial reporting in pharmaceutical companies Indonesia for 2015-2019 period. Variables The examined this are size, profitability, liquidity, leverage registered age, while is measured by structure public ownership size board commissioners. sampling method used was purposive method...

2012
Cinzia Colombo Paola Mosconi Walter Villani Silvio Garattini

BACKGROUND Many patients' and consumers' organizations accept drug industry funding to support their activities. As drug companies and patient groups move closer, disclosure become essential for transparency, and the internet could be a useful means of making sponsorship information accessible to the public. This survey aims to assess the transparency of a large group of Italian patient and con...

2012
Obiageri O. Obodozie

Discovering and developing safe and effective new medicines is a long, difficult and expensive process involving multi-billion dollar investments in Research and Development by research-based pharmaceutical industries yearly. On average, it will cost a pharmaceutical company up to $800m and upwards of 15 years to get one new medicine from the laboratory to the pharmacist's shelf. Only five in 5...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید